A uni-cortical femoral defect model in the rat: Evaluation using injectable hyaluronan hydrogel as a carrier for bone morphogenetic protein-2

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 7, 2015, Pages 799-807

  Hulsart Billström, Gry ^a   Bergman, Kristoffer ^b   Andersson, Brittmarie ^a   Hilborn, Jöns ^b   Larsson, Sune ^a   Jonsson, Kenneth B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

3R; Bone regeneration; Hydrogel; In vivo; Large femoral bone defect; Osteogenesis; Rat model

Indexed keywords

BIOMATERIALS; BONE; DEFECTS; HYALURONIC ACID; HYDROGELS; HYDROXYAPATITE; PROTEINS;

3R; BONE DEFECT; BONE REGENERATION; DEFECT MODEL; FEMORAL DEFECTS; HYALURONAN HYDROGELS; IN-VIVO; LARGE FEMORAL BONE DEFECT; OSTEOGENESIS; RAT MODEL;

RATS;

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; HYALURONIC ACID; HYDROXYAPATITE; POLYVINYL ALCOHOL; BMP2 PROTEIN, RAT; DRUG CARRIER; HYDROGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE DENSITY; BONE MINERAL; BONE REGENERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMUR; FRACTURE EXTERNAL FIXATION; HISTOLOGY; HYDROGEL; MALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; RELIABILITY; UNICORTICAL FEMORAL DEFECT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; INJURIES; METABOLISM; PHARMACOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMUR; HYALURONIC ACID; HYDROGELS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84957839313     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1655     Document Type: Article

References (42)

1. An YH, Martin KL 2003; Handbook of Histology Methods for Bone and Cartilage. Humana: Totowa, NJ.
2. Arosarena O, Collins W. 2005a; Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses. Orthodont Craniofac Res 8: 267-276.
3. Arosarena OA, Collins WL. 2005b; Bone regeneration in the rat mandible with bone morphogenetic protein-2: a comparison of two carriers. Otolaryngol Head Neck Surg 132: 592-597.
4. Aruffo A, Stamenkovic I, Melnick M, et al. 1990; CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313.
5. Bay BK, Martin RB, Sharkey NA, et al. 1993; Repair of large cortical defects with block coralline hydroxyapatite. Bone 14: 225-230.
6. Bergman K, Engstrand T, Hilborn J, et al. 2009; Injectable cell-free template for bone-tissue formation. J Biomed Mater Res A 91A: 1111-1118.
7. Boerckel JD, Kolambkar YM, Dupont KM, et al. 2011; Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 32: 5241-5251.
8. Bulpitt P, Aeschlimann D. 1999; New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 47: 152-169.
9. Carragee EJ, Hurwitz EL, Weiner BK. 2011; A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11: 471-491.
10. Darr A, Calabro A. 2009; Synthesis and characterization of tyramine-based hyaluronan hydrogels. J Mater Sci Mater Med 20: 33-44.
11. De Groot K. 1988; Effect of porosity and physicochemical properties on the stability, resorption, and strength of calcium phosphate ceramics. Ann NY Acad Sci 523: 227-233.
12. Delmage JM, Powars DR, Jaynes PK, et al. 1986; The selective suppression of immunogenicity by hyaluronic acid. Ann Clin Lab Sci 16: 303-310.
13. Dimitriou R, Mataliotakis GI, Angoules AG, et al. 2011; Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury 42(suppl 2): S3-15.
14. Docherty-Skogh A, Bergman K, Waern M, et al. 2010; Bone morphogenetic protein-2 delivered by hyaluronan-based hydrogel induces massive bone formation and healing of cranial defects in minipigs. Plast Reconstr Surg 125: 1383-1392.
15. Einhorn TA, Lane JM, Burstein AH, et al. 1984; The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. J Bone Joint Surg Am 66: 274-279.
16. Fraser JR, Laurent TC, Laurent UB. 1997; Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242: 27-33.
17. Geiger M, Li RH, Friess W. 2003; Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55: 1613-1629.
18. Hilborn J. 2011; In vivo injectable gels for tissue repair. Wiley Interdiscip Rev Nanomed Nanobiotechnol 11: 471-491.
19. Hulsart-Billstrom G, Hu Q, Bergman K, et al. 2011; Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: a study on ectopic bone formation in rats. Acta Biomater 7: 3042-3049.
20. Jia X, Colombo G, Padera R, et al. 2004; Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials 25: 4797-4804.
21. Keefe J, Wauk L, Chu S, et al. 1992; Clinical use of injectable bovine collagen: a decade of experience. Clin Mater 9: 155-162.
22. Kim J, Kim IS, Cho TH, et al. 2007; Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 28: 1830-1837.
23. Knudson W, Chow G, Knudson CB. 2002; CD44-mediated uptake and degradation of hyaluronan. Matrix Biol 21: 15-23.
24. Kurisawa M, Chung JE, Yang YY, et al. 2005; Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chem Commun (Camb) 34: 4312-4314.
25. Laurent TC, Fraser JR. 1992; Hyaluronan. FASEB J 6: 2397-2404.
26. Leibold RA, Gilula LA. 2002; Sterilization of barium for vertebroplasty: an effective, reliable, and inexpensive method to sterilize powders for surgical procedures. Am J Roentgenol 179: 198-200.
27. Manes S, Mira E, Gomez-Mouton C, et al. 2000; Cells on the move: a dialogue between polarization and motility. IUBMB Life 49: 89-96.
28. McCourt P, Ek B, Forsberg N, et al. 1994; Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 269: 30081-30084.
29. McKay WF, Peckham SM, Badura JM. 2007; A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 31: 729-734.
30. Melcher AH, Irving JT. 1962; The healing mechanism in artificially created circumscribed defects in the femora of albino rats. J Bone Jt Surg 44B: 928-936.
31. Meyer K, Palmer JW. 1934; The polysaccharide of the vitreous humor. J Biol Chem 107: 629-634.
32. Ossipov DA, Brannvall K, Forsberg-Nilsson K, et al. 2007; Formation of the first injectable poly(vinyl alcohol) hydrogel by mixing of functional PVA precursors. J Appl Polym Sci 106: 60-70.
33. Poynton AR, Lane JM. 2002; Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976) 27: S40-48.
34. Ray RD, Holloway JA. 1957; Bone implants: preliminary report of an experimental study. J Bone Joint Surg Am 39A: 1119-1128.
35. Russell WMS, Burch RL. 1959; The Principles of Humane Experimental Technique. Methuen: London.
36. Takagi K, Urist MR. 1982; The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 196: 100-109.
37. Trautinger F, Kokoschka EM, Menzel EJ. 1991; Antibody formation against human collagen and C1q in response to a bovine collagen implant. Arch Dermatol Res 283: 395-399.
38. Uludag H, Friess W, Williams D, et al. 1999; rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann NY Acad Sci 875: 369-378.
39. Wang Y, Wang X, Li H, et al. 2011; Assessing the character of the rhBMP-2- and vancomycin-loaded calcium sulphate composites in vitro and in vivo. Arch Orthop Trauma Surg 131: 991-1001.
40. Xu X, Jha AK, Harrington DA, et al. 2012; Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks. Soft Matter 8: 3280-3294.
41. Zara JN, Siu RK, Zhang X, et al. 2011; High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 17: 1389-1399.
42. Zheng Shu X, Liu Y, Palumbo FS, et al. 2004; In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 25: 1339-1348.